Theresa Hahn, PhD Theresa Hahn, PhD

Theresa Hahn

PhD
Clinical Epidemiology

Specializing In:

Clinical epidemiology Autologous & allogeneic blood & marrow transplant Survivorship Data management

Special Interests:

Genome-wide association studies Immunophenotyping by Flow Cytometry Social determinants of health

About Theresa Hahn

Biography:

I have extensive experience conducting clinical outcomes research related to blood and marrow transplantation (BMT). I have over 20 years of experience with inter- and intra-programmatic collaborative clinical and translational research to identify, understand and quantify the risk of adverse outcomes and long-term prognosis in hematologic malignancy patients treated with BMT. My research has investigated outcomes such as graft-versus-host disease, osteoporosis, chemotherapy-associated toxicity, infections and financial burden, as well as the impact of demographic and sociological factors such as age, obesity, place of residence, race, and socioeconomic status, on long-term prognosis after therapy with BMT. I have co-led multi-center, multi-disciplinary projects including:1) recipient and donor genetic susceptibility to transplant-related mortality after unrelated donor BMT, 2) immunophenotyping to detect minimal residual disease in myeloma patients treated on a 3-arm randomized controlled trial, 3) genetic susceptibility to AML, ALL and MDS. I have extensive experience leading and working as part of a variety of multidisciplinary teams on long-term projects involving complex data sources and structures. My teaching experience includes guest lectures on topics spanning ethical conduct of research, clinical epidemiology, blood & marrow transplant, and specific research projects, as well as one-on-one mentoring of students from all levels, including high school, college, graduate school, medical school, residency, clinical and graduate post-doc fellowships.

Positions

Roswell Park Comprehensive Cancer Center

  • Professor of Oncology
  • Department of Cancer Prevention and Control

Background

Education and Training:

  • PhD - Epidemiology, State University of New York at Buffalo, Buffalo, NY
  • MS - Epidemiology, State University of New York at Buffalo, Buffalo, NY
  • BS - Biochemistry from State University of New York at Geneseo, Geneseo, NY

Fellowship:

  • Hematologic Oncology/Blood and Marrow Transplant (BMT)

Professional Memberships:

  • American Society of Hematology
  • American Society for Blood and Marrow Transplantation
  • Center for International Blood and Marrow Transplant Research Registry

Honors & Awards:

  • 2019 - American Society of Blood and Marrow Transplantation Best Abstract Award
  • 2017 - American Society of Blood and Marrow Transplantation Best Abstract Award
  • 2006 - National Marrow Donor Program Medical Professional Education Award
  • 2005 - American Cancer Society Mentored Research Scholar Award

Clinical Trials


Publications

Full Publications list on PubMed

1. Hahn T, Wang J, Preus LM, Karaesmen E, Rizvi A, Clay-Gilmour AI, Zhu Q, Wang Y, Yan L, Liu S, Stram DO, Pooler L, Sheng X, Haiman CA, van den Berg D, Webb A, Brock G, Spellman SR, Onel K, McCarthy PL, Pasquini MC, Sucheston-Campbell LE. Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation. EClinicalMedicine 2021, in press

2. Herr MM, Rehman S, Zhang Y, Ho CM, Chen GL, Ross M, Hillengass J, Jacobson H, McKenzie R, Farrell K, Maqsood A, McCarthy PL, Hahn T*. Replicated risk index of patient functional status prior to allogeneic hematopoietic cell transplant predicts healthcare utilization and survival. Transplant Cell Ther 2021, in press. PMID: 34216792

3. Wang J, Clay-Gilmour AI, Karaesmen E, Rizvi A, Zhu Q, Yan L, Preus L, Liu S, Wang Y, Griffiths E, Stram DO, Pooler L, Zheng X, Hainman C, van den Berg D, Webb A, Brock G, Spellman S, Pasquini M, McCarthy PL, Allan J, Stolzel F, Onel K, Hahn T *, Sucheston-Campbell L. Genome-wide association analyses identify variants in IRF4 associated with Acute Myeloid Leukemia and Myelodysplastic Syndrome susceptibility. Preprint biorxiv: https://doi.org/10.1101/773952 and Frontiers in Genetics 2021, 12:554948. PMID: 34220922

4. Merz AMA, Merz M, Zhang Y, Stecklein K, Pleskow J, Chen GL, Buck DA, Mohammadpour H, Herr MM, Elshoury A, Hillengass J, McCarthy PL, Hahn T *. Serological response to vaccination after autologous transplantation for multiple myeloma is associated with improved progression-free and overall survival. Transplant Cell Ther 27: e1-e8, 2021.

5. Rodday AM, Hahn T, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK. Association of treatment intensity with survival in older patients with Hodgkin lymphoma. JAMA Netw Open 4(10):e2128373, 2021
10.1001/jamanetworkopen.2021.28373